ACT Immunisation Program Schedule (July 2012) - SA Health

Age/Risk GroupNATIONAL IMMUNISATION PROGRAMAustralianCapital Territory Schedule(valid from July 2012)Diseases Vaccinated AgainstVaccine Brand NameBirth2 months(may be given from 6 weeks)Hepatitis BDiphtheria, tetanus, pertussis, poliomyelitis,Haemophilus influenzae type b (Hib) and hepatitis BPneumococcalRotavirus 14 months Diphtheria, tetanus, pertussis, poliomyelitis,Haemophilus influenzae type b (Hib) and hepatitis BPneumococcalRotavirus 16 months Diphtheria, tetanus, pertussis, poliomyelitis,Haemophilus influenzae type b (Hib) and hepatitis BPneumococcal12 months Measles, mumps and rubellaHaemophilus influenzae type b (Hib)Meningococcal CChildren at high risk may require extra immunisations 218 months Varicella-Zoster (chickenpox)4 years(may be given from 3 ½years)Year 7 Hepatitis B 3Year 9Aboriginal and Torres StraitIslander people ≥ 15 yearsAboriginal and Torres StraitIslander people ≥ 50 yearsDiphtheria, tetanus, pertussis and poliomyelitisMeasles, mumps and rubellaChildren at high risk may require extra immunisations 2Varicella-Zoster (chickenpox) 4Human Papillomavirus 5Diphtheria, tetanus, pertussisInfluenza (annually)Pneumococcal (high risk only) 6 Pneumovax 23Pneumococcal6 Pneumovax 23Influenza (annually)65 years and over Pneumococcal 6 Pneumovax 23Pregnant womenInfluenza (annually)Influenza6 months – 9 years at risk Influenza (annually) 710 years – 64 years at riskInfluenza (annually) 7H-B-VaxIIPaediatricInfanrix-hexaPrevenar 13RotarixInfanrix-hexaPrevenar 13RotarixInfanrix-hexaPrevenar 13PriorixHiberixMeningitec or Neis Vac-CVarilrixInfanrix-IPVPriorixH-B-VaxIIVarilrixGardasilBoostrix, AdacelFluvax, Vaxigrip, Influvac, FluarixFluvax, Vaxigrip, Influvac, FluarixFluvax, Vaxigrip, Influvac, FluarixFluvax, Vaxigrip, Influvac, FluarixVaxigrip, Influvac, Fluarix, AgrippalFluvax*, Vaxigrip, Influvac, Fluarix,AgrippalRefer to reverse side of schedule for footnote explanations.For information contact Immunisation Enquiry Line, Health Protection Service, ACT Health on Ph: further 6205 2300.

1 RotavirusUpper age limits apply to the Rotarix vaccine. The minimum interval between doses is four weeks.Number of dosesAge of routine administration2 oral doses 2 and 4 months(4 week minimum interval between doses)Age limits for dosing1 st dose by 14.9 weeks of age2 nd dose by 24.9 weeks of age2 Children at high risk may require extra immunisationsPneumococcal Disease: Children who are considered high risk require a different vaccination schedule as defined in The AustralianImmunisation Handbook (9 th Edition) page 246. At 12 months of age, one booster dose of pneumococcal vaccine (Prevenar 13).At 4 years of age, one dose of pneumococcal vaccine (Pneumovax 23).Children with the following medical conditions ≤9 years of age: Congenital immune deficiency (including symptomatic IgG subclass or isolated IgA deficiency but excluding children who have monthlyimmunoglobulin infusions). Diseases associated with immunosuppressive therapy or radiation therapy (including corticosteroid treatment equivalent to more than2mg/kg/day of prednisone for more than 4 weeks) where there is sufficient immunity for a vaccine response to be expected. Compromised splenic function due to sickle haemoglobinopathies or congenital or acquired asplenia. Haematological malignancies HIV infection, before or after development of AIDS. Renal failure or relapsing or persistent nephrotic syndrome Down syndrome Cardiac disease associated with cyanosis or cardiac failure Premature infants with chronic lung disease Infants born less than 28 weeks gestation Cystic fibrosis Insulin dependent diabetes mellitus Proven or presumptive cerebrospinal fluid leak Intracranial shunts Cochlear implantsHepatitis B: Babies born at 5 years after 1 st dose only forthose with predisposing conditions as per ATAGI statement http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/pneumo23-atagi-statement-cnt.htm7 InfluenzaIndividuals ≥ 6 months of age with conditions predisposing to severe influenza as defined in The Australian Immunisation Handbook (9 th Edition)pages 190-191. * Fluvax® is not registered for children less than 5 years of age. The use of Influvac®, Vaxigrip®, Fluarix®, Influvac® andAgrippal® in children aged 5-9 years is strongly preferred, however Fluvax® may be used when no timely alternative vaccine is available andparents are informed of the potential increased risk of fever. Further information is available at http://immunise.health.gov.au